Aktis Oncology Inc. (AKTS)
AKTS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$16.64
-4.04% on the day
Market cap
$925.5M
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | AKTS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2026 |
| SEC CIK | 0002035832 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
New registrant: no annual report filed under this company yet.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-01-09 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-08-13 |
Source: SEC EDGAR submissions feed, 62 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.8% |
| 1 month | -25.9% |
| 3 months | -33.7% |
| Year to date | Not enough price history |
| 1 year | Not enough price history |
| From 52-week high | -48.5% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | $10.41 | -2.53% | $886.0M |
| RIGL | Rigel Pharmaceuticals Inc. | $47.14 | -3.42% | $880.6M |
| KURA | Kura Oncology Inc. | $9.83 | -5.43% | $874.5M |
| MNKD | MannKind Corporation | $3.05 | -2.56% | $980.7M |
| SVRA | Savara Inc. | $4.78 | -1.24% | $982.1M |
| OPK | OPKO Health Inc. | $1.32 | -4.35% | $985.2M |
| ANRO | Alto Neuroscience Inc. | $22.09 | -8.53% | $866.9M |
| SPTX | Seaport Therapeutics Inc. | $16.08 | -6.24% | $860.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier